Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0002007919-25-000022
Filing Date
2025-03-17
Accepted
2025-03-17 16:18:41
Documents
7

Document Format Files

Seq Description Document Type Size
1 424B3 prospectussupplementno6.htm 424B3 1589060
2 a109colorectal.jpg GRAPHIC 106825
3 image_4.jpg GRAPHIC 43872
4 image_8.jpg GRAPHIC 41538
5 inbrx-106blank.jpg GRAPHIC 162808
6 inbrx-109blank.jpg GRAPHIC 166858
7 inbrx-109chart.jpg GRAPHIC 194324
  Complete submission text file 0002007919-25-000022.txt   2576821
Mailing Address 11025 N. TORREY PINES ROAD, SUITE 140 LA JOLLA CA 92037
Business Address 11025 N. TORREY PINES ROAD, SUITE 140 LA JOLLA CA 92037 (858) 795-4220
Inhibrx Biosciences, Inc. (Filer) CIK: 0002007919 (see all company filings)

EIN.: 990613523 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-280127 | Film No.: 25744720
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)